(Q40539267)

21 September 2017

title

Optimization of a synthetic beta-catenin-dependent promoter for tumor-specific cancer gene therapy (English)

1 reference

21 September 2017

0 references

1 reference

5

1 reference

21 September 2017

Kai S Lipinski

1

1 reference

21 September 2017

Hakim A Djeha

2

1 reference

21 September 2017

Jonathan Gawn

3

1 reference

21 September 2017

Suzanne Cliffe

4

1 reference

21 September 2017

Daniel H Palmer

6

1 reference

21 September 2017

Andrew Mountain

7

1 reference

21 September 2017

Alistair S Irvine

8

1 reference

21 September 2017

Christopher J Wrighton

9

1 reference

21 September 2017

publication date

1 July 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

10

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

150-161

1 reference

Cancer gene therapy: fringe or cutting edge?

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Latest development in viral vectors for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Cancer gene therapy: hard lessons and new courses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Recombinant adenovirus vectors with knobless fibers for targeted gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Targeting of adenoviral vectors through a bispecific single-chain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Progress in transcriptionally targeted and regulatable vectors for genetic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

A strategy for enhancing the transcriptional activity of weak cell type-specific promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

APC, signal transduction and genetic instability in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

PTEN: a new twist on β-catenin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Modulation of the specificity and activity of a cellular promoter in an adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Dendritic cells for the immunotherapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

PG13 packaging cells produce recombinant retroviruses carrying a diphtheria toxin mutant which kills cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Stabilization of beta-catenin by genetic defects in melanoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Detection and analysis of beta-catenin mutations in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Nuclear localization and formation of beta-catenin-lymphoid enhancer factor 1 complexes are not sufficient for activation of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Differential expression of beta-catenin in human glioblastoma multiforme and normal brain tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Interactions of a DNA-bound transcriptional activator with the TBP-TFIIA-TFIIB-promoter quaternary complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Tetracycline-controlled expression but not toxicity of an attenuated diphtheria toxin mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

CL22 - a novel cationic peptide for efficient transfection of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

Efficient nonviral transfection of dendritic cells and their use for in vivo immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.021

10.1016/J.YMTHE.2004.03.021

7 January 2021

Identifiers

DOI

1 reference

release_ugrdonosjrexzksbuzthrr72oa

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugrdonosjrexzksbuzthrr72oa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference